1/49
If I have to suffer, you do too.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Comparing proportion of a population to 1 group
Z test, Chi square(X2)?
Comparing proportion of 2 independent groups
Z test, Chi square(X2)
Comparing proportion of 3+ independent groups
Chi square(X2)
Comparing proportion for SMALL SAMPLES
Fisher’s Exact Test
Comparing proportions in:
ONE(dependent/matched/paired) group for
Before/After type exposure or…
Multiple exposures (still only 1 group)
Mcnemar's Test
Comparing proportions or means in
2 groups when NONPARAMETRIC DATA
Mann-Whitney U Test (Wilcoxon rank-sum test)
Comparing proportions or means in
3+ groups comparison when data is NONPARAMETRIC DATA
Kruskal-Wallis Test
Comparing means of:
1 group mean to a hypothesized population mean
One sample t-test
Comparing means of:
2 independent groups
Independent/Unpaired t-test
or just “t-test”
ANOVA
Comparing means of:
3 independent groups
ANOVA
Comparing means of:
2 dependent sample means (1 group)
→ Before/after or 1 group - 2 exposures
Dependent/Matched/Paired t-test
Comparing means of:
2 groups(out of 3+) after ANOVA determined a difference…
Post hoc pairwise group analyses
ie. Tukey’s HSD test
Bonferroni’s Correction Method
Comparing means of:
2 groups(out of 3+) after ANOVA by adjusting α via → α/ total # of comparisons = new alpha
Bonferroni's Correction Method
Comparing means of:
2 groups(out of 3+) after ANOVA by adjusting p-values via statistical software and use same alpha
Tukey’s HSD
Comparing means of:
Groups which differ in 2 factors (ie. smoking & physical activity)
two-way ANOVA
Comparing means of:
Groups which differ in 3 factors (ie. smoking & physical activity & DASH diet)
multi-factor ANOVA
Comparing means of:
Dependent/Matched/Paired groups with 3+ time points or interventions
Repeated Measure ANOVA
Comparing means of:
Dependent/matched/paired for NONPARAMETRIC DATA
Wilcoxon signed-rank test
Formula to traditionally calculate correlation coefficient (r)
Pearson’s product-moment correlation
Pearson’s r
Pearson’s correlation coefficient
Formula to calculate correlation coefficient (r) when NONPARAMETRIC
Spearman’s Rank Correlation
Formula to calculate correlation coefficient (r) when ORDINAL
Kendall’s Rank Correlation
Type of regression with:
1 continuous or categorical predictor variable (x)
1 continuous outcome variable (y)
Simple Linear Regression
Linear Regression
Type of regression with:
Multiple continuous &/or categorical predictor variables (x)
1 continuous outcome variable (y)
Multiple Linear Regression
Multiple Regression
Type of regression with:
1 continuous or categorical predictor variable (x)
1 dichotomous outcome variable (y)
Simple Logistic Regression
Logistic Regression
Type of regression with:
Multiple continuous &/or categorical predictor variable (x)
1 dichotomous outcome variable (y)
Multiple Logistic Regression
Type of regression with:
1+ continuous &/or categorical predictor variable(s) (x)
1 nominal outcome variable with 3 or more categories (y)
Multinomial Logistic Regression
Statistical method which uses fixed/variable intervals to tabulate time until an event is experienced with cumulative event-free probabilities (Survival Analysis)
Life Tables
Statistical method which uses exact times until an event is experienced with cumulative proportions recalculated every time an event occurs (Survival Analysis)
Kaplan Meier Curve
Test comparing:
2+ treatment groups for a statistically significant difference in survival rates(Kaplan Meier-Survival Analysis)
log-rank test (Mantel-Cox test)
2 groups(out of 3+) after log-rank test determined a difference in survival rates
Post-hoc log-rank tests
Statistical method which allows the investigators to predict relationship between explanatory variable(s) (x) and time to an event as an outcome (y) (Survival Analysis)
Cox Proportional Hazards Model
Measure of association provided by Cox Regression
Hazard Ratio
Description of unexplained outcomes to treatment with detailed descriptions of patient characteristics, in an individual patient
Case Report
Description of unexplained outcomes to treatment with detailed descriptions of patient characteristics, in a few patients with the same disease, exposure, or outcome.
Case Series
Benefits:
Identify new Diseases, drug Side Effects, new drug Uses
Descriptive, generates hypotheses for other study designs
Limitations
Definitive associations/causal effects cannot be drawn between the exposure and outcome from such few cases
Case Reports & Series
Prevalence of health information either exposure or outcome at a single point in time in a defined population
Cross-Sectional Studies
Prevalence studies
Benefits:
Mostly descriptive, but can be used to evaluate associations between exposures and outcomes, generating hypotheses for future studies
Valuable in assessing health needs/outcomes of populations and comparing them to others.
Relatively inexpensive & easy to conduct
Limitations
associations may not be reliable because of assessing both exposure and outcome at a single point in time
Cannot establish temporality of events
Do not establish causality
Cross-Sectional
Compare disease(cases) to matched individuals without the disease (controls)
Reviews retrospective data to evaluate relationship between outcome and predictor
Case-control
Benefits
Data easy to obtain (eMR/databases)
Useful when RCT is unethical
Better for rare outcomes
Less expensive than RCT and prospective cohort
Limitations
Associations (No causality)
Matching is not perfect → confounders
Recall bias (cases better at recalling than controls)
Case control
Follow a group of exposed individuals to matched individuals not exposed to see if they develop an outcome of interest
Prospective or Retrospective
Cohort
Benefits
Useful when intervention is unethical or when exposure is rare
Time sequence of events (exposure→ outcome) can be determined
Less expensive than RCTs
Limitations
Prospective → expensive & time-consuming
Prospective → Loss to follow-up is a possibility
Influenced by confounders
Cohort
Design for establishing causality
Compare experimental treatment to existing/placebo to determine superiority, equivalence, or noninferiority
Sampled with specific inclusion, & exclusion criteria
Randomized to study treatment groups
Subjects are usually blinded (potentially investigators & analysts too)
Randomized Controlled Trials
Benefits
Randomization ensures equal chance of intervention, and have similar characteristics → minimizes selection bias & confounding (compared to observational)
Best design of cause-effect between intervention & outcome
Limitations
Time-consuming & Expensive
Not for unethical interventions or lack thereof with randomization
Not for rare outcomes
May not be real-world (external validity issues due to restrictive exclusion criteria)
Randomized Controlled Trials
Summary of clinical literature - specific topic like treatment options for a condition or side effects of a drug
Begins with a question and systematic literature search and presented in an unbiased, balance summary
Systematic review
Benefits
Inexpensive since studies already exist
Several studies included provide stronger evidence
Limitations
Summary without pooled statistical estimate
Systematic Review
Combine results from multiple studies & provide a pooled single statistical estimate of the effect size or magnitude of treatment effect from all reviewed studies
Meta Analyses
Benefits
Smaller studies can be pooled instead of 1 large expensive study
Pooled = greater statistical power
Limitations
Studies may not be homogenous
design, exposure, outcome, sample size, inclusion/exclusion criteria
Validity can be compromised if lower quality is weighted equally to higher quality studies
Meta Analyses
If a case is better able to remember details of their exposures this bias is…
Recall bias.
Disease rates, or exposures made on group of people (house, hospital, countries)
Benefits
Useful to compare health in different populations
Generating questions for future hypotheses
Ecological